• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problem Malposition of Device (2616)
Patient Problems Myocardial Infarction (1969); Heart Failure/Congestive Heart Failure (4446)
Event Date 03/26/2021
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: partial or total occlusion or obstruction of the coronary ostia is a recognized complication of an aortic valve replacement.It is typically the result of a technical error during valve implant and not related to a product malfunction.However, partial, or total occlusion of the ostia, if unrecognized, can result in angina, myocardial infarction, acute ventricular dysfunction and/or death.The root cause of this event cannot be determined with the available information.It is unknown if the patient and/or procedure-related factors may have caused or contributed to this event.There has been no allegation of a product malfunction.The subject device is not available for evaluation as it was never received.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, an appropriate investigation will be performed.If any new information is received, a supplemental report will be submitted accordingly.
 
Event Description
Through implant patient registry, it was learned that a patient with a 23mm 11500a aortic valve was explanted at implant due to obstruction of the coronary ostium.The explanted valve was replaced with a non-edwards valve.Per the medical records, the patient previously placed homograft was densely calcified with perforation of both the left and right leaflets.The ostia were low-lying, and a full root repair was not unexpected.The patient underwent an aortic root enlargement with a bovine pericardial patch and a 23mm 11500a was implanted.The aorta was closed but there was new lv hypokinesis and multiple arrhythmias.There was ostial obstruction, so the valve and patch were explanted.The subsequent root replacement was successful, using a 25 mm non edwards valve within a pig root, and a 26mm dacron graft.The patient tolerated the procedure well and was transferred to the icu in stable condition.On pod #4, the patient was discharged home in stable condition, on new oxygen, cardiac, antiplatelet, and diuretic therapy.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
H11: corrective data: corrected section: h6 (investigation findings, and investigation conclusions).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key11733110
MDR Text Key252262858
Report Number2015691-2021-02693
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194982
UDI-Public00690103194982
Combination Product (y/n)N
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 06/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/07/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age44 YR
Patient Weight85
-
-